Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study.
Saved in:
| Title: | Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study. |
|---|---|
| Authors: | Tsimikas S; University of California San Diego, La Jolla, CA, USA; Isis Pharmaceuticals, Carlsbad, CA, USA. Electronic address: stsimikas@ucsd.edu., Viney NJ; Isis Pharmaceuticals, Carlsbad, CA, USA., Hughes SG; Isis Pharmaceuticals, Carlsbad, CA, USA., Singleton W; Isis Pharmaceuticals, Carlsbad, CA, USA., Graham MJ; Isis Pharmaceuticals, Carlsbad, CA, USA., Baker BF; Isis Pharmaceuticals, Carlsbad, CA, USA., Burkey JL; Isis Pharmaceuticals, Carlsbad, CA, USA., Yang Q; Isis Pharmaceuticals, Carlsbad, CA, USA., Marcovina SM; University of Washington, Seattle, WA, USA., Geary RS; Isis Pharmaceuticals, Carlsbad, CA, USA., Crooke RM; Isis Pharmaceuticals, Carlsbad, CA, USA., Witztum JL; University of California San Diego, La Jolla, CA, USA. |
| Source: | Lancet (London, England) [Lancet] 2015 Oct 10; Vol. 386 (10002), pp. 1472-83. Date of Electronic Publication: 2015 Jul 22. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1474-547X |
|---|---|
| DOI: | 10.1016/S0140-6736(15)61252-1 |
